Michael L. Mitchell

1.9k total citations · 1 hit paper
22 papers, 1.3k citations indexed

About

Michael L. Mitchell is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Michael L. Mitchell has authored 22 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Organic Chemistry and 6 papers in Infectious Diseases. Recurrent topics in Michael L. Mitchell's work include Carbohydrate Chemistry and Synthesis (7 papers), HIV Research and Treatment (6 papers) and HIV/AIDS drug development and treatment (6 papers). Michael L. Mitchell is often cited by papers focused on Carbohydrate Chemistry and Synthesis (7 papers), HIV Research and Treatment (6 papers) and HIV/AIDS drug development and treatment (6 papers). Michael L. Mitchell collaborates with scholars based in United States, South Korea and Belgium. Michael L. Mitchell's co-authors include Chi‐Huey Wong, Lac V. Lee, K. Barry Sharpless, Valery V. Fokin, Ian A. Wilson, A. Heine, J.G. Luz, Grace DeSantis, Masangu Shabangi and James R. Fuchs and has published in prestigious journals such as Science, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Michael L. Mitchell

22 papers receiving 1.3k citations

Hit Papers

A Potent and Highly Selective Inhibitor of Human α-1,3-Fu... 2003 2026 2010 2018 2003 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael L. Mitchell United States 14 799 734 186 163 155 22 1.3k
Kevin Parris United States 21 794 1.0× 353 0.5× 121 0.7× 69 0.4× 344 2.2× 32 1.4k
Christiane Yoakim Canada 28 624 0.8× 1.1k 1.5× 306 1.6× 257 1.6× 59 0.4× 51 1.8k
Patricia A. Benkovic United States 25 1.3k 1.7× 575 0.8× 159 0.9× 63 0.4× 158 1.0× 43 2.0k
Björn Classon Sweden 21 727 0.9× 763 1.0× 370 2.0× 201 1.2× 47 0.3× 67 1.3k
Maria Bretner Poland 25 1.1k 1.3× 630 0.9× 270 1.5× 72 0.4× 147 0.9× 82 1.9k
Roger Bone United States 21 934 1.2× 401 0.5× 115 0.6× 45 0.3× 287 1.9× 33 1.6k
Hosahudya N. Gopi India 27 1.3k 1.6× 981 1.3× 113 0.6× 123 0.8× 108 0.7× 102 1.8k
M. Arshad Siddiqui United States 27 1.4k 1.7× 1.2k 1.6× 558 3.0× 162 1.0× 52 0.3× 86 2.4k
Neville J. Anthony United States 14 992 1.2× 531 0.7× 373 2.0× 315 1.9× 45 0.3× 24 1.5k
Yun He United States 21 529 0.7× 918 1.3× 133 0.7× 69 0.4× 41 0.3× 52 1.5k

Countries citing papers authored by Michael L. Mitchell

Since Specialization
Citations

This map shows the geographic impact of Michael L. Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael L. Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael L. Mitchell more than expected).

Fields of papers citing papers by Michael L. Mitchell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael L. Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael L. Mitchell. The network helps show where Michael L. Mitchell may publish in the future.

Co-authorship network of co-authors of Michael L. Mitchell

This figure shows the co-authorship network connecting the top 25 collaborators of Michael L. Mitchell. A scholar is included among the top collaborators of Michael L. Mitchell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael L. Mitchell. Michael L. Mitchell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Balakrishnan, Mini, et al.. (2021). GS-9822, a Preclinical LEDGIN Candidate, Displays a Block-and-Lock Phenotype in Cell Culture. Antimicrobial Agents and Chemotherapy. 65(5). 24 indexed citations
2.
Roberts, Ruth, Richard A. Campbell, C Sadler, et al.. (2021). Species-Specific Urothelial Toxicity With an Anti-HIV Noncatalytic Site Integrase Inhibitor (NCINI) Is Related to Unusual pH-Dependent Physicochemical Changes. Toxicological Sciences. 183(1). 105–116. 1 indexed citations
3.
Li, Shuaizhang, Jinghua Zhao, Ruili Huang, et al.. (2017). Development and Application of Human Renal Proximal Tubule Epithelial Cells for Assessment of Compound Toxicity. PubMed. 11(1). 19–30. 36 indexed citations
4.
Mitchell, Michael L., Lianhong Xu, Zachary E. Newby, & Manoj C. Desai. (2017). Synthesis of novel HIV-1 protease inhibitors via diastereoselective Henry reaction with nitrocyclopropane. Tetrahedron Letters. 58(12). 1123–1126. 4 indexed citations
5.
Tsiang, Manuel, G.S. Jones, Anita Niedziela‐Majka, et al.. (2012). New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action. Journal of Biological Chemistry. 287(25). 21189–21203. 129 indexed citations
6.
Tsiang, Manuel, G.S. Jones, Magdeleine Hung, et al.. (2011). Dithiothreitol Causes HIV-1 Integrase Dimer Dissociation While Agents Interacting With the Integrase Dimer Interface Promote Dimer Formation. Biochemistry. 50(10). 1567–1581. 15 indexed citations
7.
Mitchell, Michael L., Jong Chan Son, Hongyan Guo, et al.. (2010). N1-Alkyl pyrimidinediones as non-nucleoside inhibitors of HIV-1 reverse transcriptase. Bioorganic & Medicinal Chemistry Letters. 20(5). 1589–1592. 12 indexed citations
8.
Mitchell, Michael L., Jong Chan Son, Ill Young Lee, et al.. (2010). N1-Heterocyclic pyrimidinediones as non-nucleoside inhibitors of HIV-1 reverse transcriptase. Bioorganic & Medicinal Chemistry Letters. 20(5). 1585–1588. 19 indexed citations
9.
Wada, Masaru, Che‐Chang Hsu, Dirk Franke, et al.. (2003). Directed evolution of N-acetylneuraminic acid aldolase to catalyze enantiomeric aldol reactions. Bioorganic & Medicinal Chemistry. 11(9). 2091–2098. 68 indexed citations
11.
Mitchell, Michael L., Lac V. Lee, & Chi‐Huey Wong. (2002). Synthesis and evaluation of six-membered GDP-iminocyclitol. Tetrahedron Letters. 43(32). 5691–5693. 14 indexed citations
13.
Heine, A., Grace DeSantis, J.G. Luz, et al.. (2001). Observation of Covalent Intermediates in an Enzyme Mechanism at Atomic Resolution. Science. 294(5541). 369–374. 239 indexed citations
14.
Mitchell, Michael L., et al.. (2001). Chemical-Enzymatic Synthesis of Iminocyclitol Phosphonic Acids. Advanced Synthesis & Catalysis. 343(6-7). 596–599. 1 indexed citations
15.
Mitchell, Michael L., et al.. (2001). Chemical-Enzymatic Synthesis of Iminocyclitol Phosphonic Acids. Advanced Synthesis & Catalysis. 343(6-7). 596–599. 14 indexed citations
16.
Mitchell, Michael L., et al.. (1999). Synthesis of deuterium labeled FAD-C44. Journal of Labelled Compounds and Radiopharmaceuticals. 42(1). 17–22. 1 indexed citations
17.
Fuchs, James R., Michael L. Mitchell, Masangu Shabangi, & Robert A. Flowers. (1997). The effect of lithium bromide and lithium chloride on the reactivity of SmI2 in THF. Tetrahedron Letters. 38(47). 8157–8158. 75 indexed citations
18.
Tropea, Joseph E., Russell J. Molyneux, Gagan Kaushal, et al.. (1989). Australine, a pyrrolizidine alkaloid that inhibits amyloglucosidase and glycoprotein processing. Biochemistry. 28(5). 2027–2034. 89 indexed citations
19.
Magde, Douglas, Jean‐Louis Martin, Kent R. Wilson, et al.. (1985). Femtosecond Laser Studies Of Distal Side Effects In Myoglobin And Model Compounds. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 533. 2–2. 1 indexed citations
20.
Traylor, Teddy G., Shinji Tsuchiya, D. H. Campbell, et al.. (1985). Anthracene heme cyclophanes. Steric effects in carbon monoxide, molecular oxygen, and RNC binding. Journal of the American Chemical Society. 107(3). 604–614. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026